In summary, the CD4 marker is characteristic of cutaneous T-cell lymphomas (CTCL) and the CD20 and CD79α markers are features of cutaneous B-cell lymphomas (CBCL). The gene discussed is CD4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.